Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS
1 other identifier
observational
40
1 country
1
Brief Summary
Although the theoretical model of "cyclic on-off switching of pulmonary blood flow" provides a crucial perspective for understanding VILI, its clinical validation and real-time intervention face significant obstacles. The fundamental reason lies in the lack of pulmonary microcirculation monitoring technology capable of bedside, non-invasive, continuous operation with sufficient spatiotemporal resolution. Nowadays, a novel 3D-EIT can perform real-time and non-invasive assessment of the distribution of pulmonary blood flow. However, if 3D-EIT can help to identify "cyclic on-off switching of pulmonary blood flow" is still unclear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
January 8, 2026
December 1, 2025
8 months
December 25, 2025
December 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The percent of "Cyclic On-Off Switching"
"Cyclic On-Off Switching" was assessed by 3D-EIT
15min
Study Arms (3)
phase 1
patients ventilated with a tidal volume of 4ml/kg pbw
phase 2
patients ventilated with a tidal volume of 6ml/kg pbw
phase 3
patients ventilated with a tidal volume of 8ml/kg pbw
Eligibility Criteria
Consecutive adult patients admitted to our ICU were screened for inclusion and exclusion criteria
You may qualify if:
- Adult patients with mechanical ventilation
- diagnosis of moderate to severe ARDS no more than 72 hours
You may not qualify if:
- Chronic respiratory diseases that required long-term oxygen therapy, such as pulmonary fibrosis or chronical obstructive pulmonary disease
- Contraindications to EIT (e.g., active implantable device, chest malformation, unstable spinal injuries or fractures, and open chest wounds)
- Undrained pneumothorax or pneumomediastinum,
- Hemodynamic instability
- Pregnancy
- Refusal by family or the attending physician to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongda Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, 210009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 28 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 25, 2025
First Posted
January 8, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
January 8, 2026
Record last verified: 2025-12